Kidney failure or cancer. Should immunosuppression be continued in a transplant patient with malignant melanoma?
D000328:Adult; D001379:Azathioprine / Q000009:adverse effects; D004198:Disease Susceptibility; D005260:Female; D005921:Glomerulonephritis / Q000628:therapy*; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D008545:Melanoma / Q000209:etiology*; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects; D011336:Probability; D011379:Prognosis; D011788:Quality of Life; D006435:Renal Dialysis / Q000009:adverse effects; D012306:Risk; D012878:Skin Neoplasms / Q000209:etiology*; D014481:United States
D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone